An agreement was made during the meeting of the Presidents of Finland and Russia on co-operation between Turku Science Park Ltd, universities in Turku and the Skolkovo science and technology cluster that is rising near Moscow. The University of Turku, Åbo...
Компания « НейроМакс », резидент Фонда «Сколково», успешно завершила фазу Ia клинических исследований по изучению безопасности и фармакокинетики разрабатываемого препарата NM-IA-001 (холина диэпалрестат, BNV-222) у пациентов с диабетической...
NeuroMax has successfully completed Phase Ia clinical trials on the safety and pharmacokinetics of drug candidate NM-IA-001 (BNV-222) for patients with diabetic neuropathy. Previously approved by the Ministry of Health of the Russian Federation the study was...